awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q44251536-2309CC2D-F116-4C92-A36A-BC377C7BCB51
Q44251536-2309CC2D-F116-4C92-A36A-BC377C7BCB51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44251536-2309CC2D-F116-4C92-A36A-BC377C7BCB51
Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial.
P2860
Q44251536-2309CC2D-F116-4C92-A36A-BC377C7BCB51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44251536-2309CC2D-F116-4C92-A36A-BC377C7BCB51
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
edf26220a7e3058c47ac07e59bd27345f7cd45b0
P2860
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).